o-demethyltramadol has been researched along with Critical Illness in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allegaert, K; Cossey, V; de Hoon, J; van den Anker, JN; van Fessem, M; van Schaik, RH; Vanhole, C; Verbesselt, R; Vermeersch, S | 1 |
1 trial(s) available for o-demethyltramadol and Critical Illness
Article | Year |
---|---|
Postmenstrual age and CYP2D6 polymorphisms determine tramadol o-demethylation in critically ill neonates and infants.
Topics: Analgesics, Opioid; Biotransformation; Birth Weight; Critical Illness; Cytochrome P-450 CYP2D6; Dealkylation; Drug Administration Schedule; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Models, Biological; Pharmacogenetics; Polymorphism, Genetic; Tramadol | 2008 |